Avanir Pharmaceuticals,Incorporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Avanir Pharmaceuticals,Incorporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Avanir Pharmaceuticals,Incorporation Formerly known as AVANIR Pharmaceuticals. The Group's principal activity is to develop, acquire and commercialize novel therapeutic products for the treatment of chronic diseases. The product candidate address therapeutic markets that include the central nervous system and inflammatory diseases. The product candidate Zenvia is in the phase III clinical development for the treatment of pseudobulbar affect and diabetic peripheral neuropathic pain. The Group also has an ongoing development program with Novartis for the treatment of inflammatory disease.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report